News & Updates

Perimetric glaucoma may develop in eyes with pseudoexfoliation syndrome (PXF) with or without ocular hypertension (OHTN), suggests a recent study. Factors such as older age, OHTN, higher cup-to-disc ratio (CDR), and phakia are associated with incident glaucoma.

An AI-based optical coherence tomography (AI-OCT) system for add-on secondary screening of diabetic macula oedema (DME) reduces false-positive DME referrals by 45 percent vs standard screening by fundus photography alone, a randomized controlled trial (RCT) in Hong Kong has shown.

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in an increased risk for ischaemic optic neuropathy (ION) at 18 months when compared with the use of sodium‒glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is), reports a study.

The overall development of vision-threatening diabetic retinopathy (DR) among Asians with diabetes is low, although the incidence of progression to vision-threatening disease for those who already have DR is high, according to local research.

New drug applications approved by US FDA as of 1-15 June 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Social determinants of health (SDOH) are significantly associated with maxillofacial trauma, suggests a US study. These SDOH factors include substance use, unhoused status, and poverty, among others

Long-term treatment with intravitreal antivascular endothelial growth factor (anti-VEGF) appears to elevate the risk of developing cataract that requires surgical intervention, reports a study.

A diagnostic accuracy study shows greater overall diagnostic sensitivity with a traditional autorefraction device than with a newer, distinct photoscreening device—a retinal birefringence scanner (RBS)—for detecting amblyopia and refractive errors in children.

Satralizumab reduces the risk of relapse by 68 percent in adults and adolescents with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), as shown in the phase III METEOROID study presented at AAN 2026.